Aloracetam

Aloracetam
Clinical data
ATC code	none;
Legal status
Legal status	US: Unscheduled Not FDA approved;
Identifiers
	IUPAC name N-[2-(3-Formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide;
CAS Number	119610-26-3 ;
PubChem CID	178134;
ChemSpider	155069 ;
UNII	U0RKZ75D0T;
ChEMBL	ChEMBL2104637;
CompTox Dashboard (EPA)	DTXSID10152524 ;
Chemical and physical data
Formula	C11H16N2O2
Molar mass	208.261 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=CC(=C(N1CCNC(=O)C)C)C=O;
	InChI InChI=1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15) ; Key:ZUQSGZULKDDMEW-UHFFFAOYSA-N ;
	(verify)

Aloracetam (INN) is a drug described as a nootropic which is closely related to, but technically not of (as it lacks a pyrrolidone ring), the racetam family of compounds.^[1]^[2]^[3] It was studied by Aventis for the treatment of Alzheimer's disease,^[4] but was never marketed.

References

↑ "The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" (PDF). World Health Organization. 2011. Retrieved 22 May 2015.
↑ George CF (7 July 1998). Drug Therapy in Old Age. Wiley. ISBN 978-0-471-94149-1.
↑ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 615–. ISBN 978-0-412-46630-4.
↑ Fischer F, Matthisson M, Herrling P (2004). "List of drugs in development for neurodegenerative diseases". Neuro-Degenerative Diseases. 1 (1): 50–70. doi:10.1159/000077879. PMID 16908974.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.